Restructuring	3 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring In February 2020, as part of our strategy to better align our capital resources with our commercialization plan, we undertook a reduction in headcount. During the three months ended March 31, 2020, we recorded a net restructuring charge of $1.9 million, of which $0.8 million is included within research and development expense and $1.1 million is included within general and administrative expense on our Condensed Consolidated Statements of Operations. During the three months ended March 31, 2020, we paid $0.9 million of severance. At March 31, 2020, the accrued liability for the severance charge was $1.0 million and is included within accrued and other liabilities on the Condensed Consolidated Balance Sheets. We expect to substantially pay the remaining restructuring liabilities by the end of the fourth quarter of 2020. Related to this restructure event, there are no significant remaining costs expected to be incurred subsequent to March 31, 2020.

Restructuring

3 Months Ended

Mar. 31, 2020

Restructuring and Related Activities [Abstract]

In February 2020, as part of our strategy to better align our capital resources with our commercialization plan, we undertook a reduction in headcount. During the three months ended March 31, 2020, we recorded a net restructuring charge of $1.9 million, of which $0.8 million is included within research and development expense and $1.1 million is included within general and administrative expense on our Condensed Consolidated Statements of Operations. During the three months ended March 31, 2020, we paid $0.9 million of severance. At March 31, 2020, the accrued liability for the severance charge was $1.0 million and is included within accrued and other liabilities on the Condensed Consolidated Balance Sheets. We expect to substantially pay the remaining restructuring liabilities by the end of the fourth quarter of 2020. Related to this restructure event, there are no significant remaining costs expected to be incurred subsequent to March 31, 2020.